Cargando…
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
BACKGROUND: The heterogeneous behavior of patients with melanoma makes prognostication challenging. To address this, a gene expression profile (GEP) test to predict metastatic risk was previously developed. This study evaluates the GEP’s prognostic accuracy in an independent cohort of cutaneous mela...
Autores principales: | Zager, Jonathan S., Gastman, Brian R., Leachman, Sancy, Gonzalez, Rene C., Fleming, Martin D., Ferris, Laura K., Ho, Jonhan, Miller, Alexander R., Cook, Robert W., Covington, Kyle R., Meldi-Plasseraud, Kristen, Middlebrook, Brooke, Kaminester, Lewis H., Greisinger, Anthony, Estrada, Sarah I., Pariser, David M., Cranmer, Lee D., Messina, Jane L., Vetto, John T., Wayne, Jeffrey D., Delman, Keith A., Lawson, David H., Gerami, Pedram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800282/ https://www.ncbi.nlm.nih.gov/pubmed/29402264 http://dx.doi.org/10.1186/s12885-018-4016-3 |
Ejemplares similares
-
Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck
por: Gastman, Brian R., et al.
Publicado: (2019) -
Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma
por: Gerami, Pedram, et al.
Publicado: (2016) -
A Study of 523 Cases of Obesity
por: Dunlop, D. M., et al.
Publicado: (1931) -
Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies
por: Dhillon, Soneet, et al.
Publicado: (2023) -
Correction: Routine imaging guided by a 31‑gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies
por: Dhillon, Soneet, et al.
Publicado: (2023)